Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Fusion | 11 | 2010 | 29 | 1.500 |
Why?
|
| Virus Internalization | 5 | 2021 | 18 | 1.400 |
Why?
|
| Viral Fusion Proteins | 6 | 2020 | 15 | 1.380 |
Why?
|
| HIV-1 | 7 | 2009 | 205 | 0.970 |
Why?
|
| Gene Products, env | 8 | 2009 | 14 | 0.960 |
Why?
|
| Endosomes | 3 | 2021 | 8 | 0.960 |
Why?
|
| Lassa virus | 2 | 2021 | 4 | 0.770 |
Why?
|
| Lassa Fever | 1 | 2021 | 2 | 0.740 |
Why?
|
| Monoglycerides | 1 | 2021 | 2 | 0.740 |
Why?
|
| Lysophospholipids | 1 | 2021 | 3 | 0.740 |
Why?
|
| Viral Envelope Proteins | 4 | 2021 | 13 | 0.650 |
Why?
|
| Cell Membrane | 4 | 2010 | 89 | 0.650 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 6 | 2013 | 12 | 0.620 |
Why?
|
| Membrane Potentials | 2 | 2010 | 167 | 0.590 |
Why?
|
| Cell Line | 12 | 2013 | 260 | 0.530 |
Why?
|
| HIV Envelope Protein gp41 | 5 | 2005 | 12 | 0.520 |
Why?
|
| Ebolavirus | 1 | 2016 | 6 | 0.500 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 7 | 0.490 |
Why?
|
| Cell Fusion | 6 | 2010 | 10 | 0.480 |
Why?
|
| Viral Proteins | 1 | 2013 | 12 | 0.420 |
Why?
|
| Animals | 13 | 2021 | 3503 | 0.400 |
Why?
|
| HEK293 Cells | 4 | 2021 | 62 | 0.380 |
Why?
|
| COS Cells | 4 | 2021 | 39 | 0.370 |
Why?
|
| Virion | 3 | 2020 | 12 | 0.370 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 2016 | 131 | 0.350 |
Why?
|
| Peptides | 3 | 2009 | 100 | 0.340 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 61 | 0.320 |
Why?
|
| Lipids | 2 | 2009 | 48 | 0.310 |
Why?
|
| HIV | 1 | 2009 | 39 | 0.310 |
Why?
|
| Protein Folding | 3 | 2004 | 17 | 0.310 |
Why?
|
| Cell Membrane Permeability | 2 | 2007 | 52 | 0.290 |
Why?
|
| Avian Sarcoma Viruses | 2 | 2004 | 2 | 0.280 |
Why?
|
| Semliki forest virus | 1 | 2007 | 3 | 0.280 |
Why?
|
| Temperature | 7 | 2007 | 61 | 0.240 |
Why?
|
| Humans | 17 | 2021 | 25967 | 0.230 |
Why?
|
| Kinetics | 4 | 2009 | 178 | 0.220 |
Why?
|
| Flow Cytometry | 2 | 2016 | 106 | 0.200 |
Why?
|
| Antiviral Agents | 2 | 2020 | 66 | 0.190 |
Why?
|
| CD4 Antigens | 4 | 2005 | 29 | 0.180 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2000 | 2 | 0.170 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Viruses | 1 | 2020 | 4 | 0.170 |
Why?
|
| Salicylates | 1 | 2020 | 6 | 0.170 |
Why?
|
| DNA Viruses | 1 | 2020 | 5 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 98 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 22 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2019 | 169 | 0.140 |
Why?
|
| Influenza A virus | 2 | 2019 | 14 | 0.140 |
Why?
|
| Fluorescent Dyes | 2 | 2010 | 34 | 0.130 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 153 | 0.130 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 190 | 0.130 |
Why?
|
| Cathepsins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 55 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2016 | 145 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 368 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2005 | 37 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 29 | 0.110 |
Why?
|
| Protein Structure, Secondary | 2 | 2004 | 21 | 0.110 |
Why?
|
| 3T3 Cells | 3 | 2004 | 9 | 0.110 |
Why?
|
| Cricetinae | 3 | 2013 | 35 | 0.110 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2013 | 5 | 0.110 |
Why?
|
| Models, Biological | 4 | 2004 | 318 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Protein Conformation | 4 | 2004 | 68 | 0.090 |
Why?
|
| Erythrocytes | 3 | 2000 | 18 | 0.090 |
Why?
|
| Point Mutation | 2 | 2001 | 25 | 0.090 |
Why?
|
| Fluorescence | 1 | 2010 | 8 | 0.080 |
Why?
|
| Electricity | 1 | 2010 | 8 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 166 | 0.080 |
Why?
|
| Time Factors | 3 | 2010 | 1391 | 0.080 |
Why?
|
| CHO Cells | 2 | 2000 | 11 | 0.080 |
Why?
|
| Mutation | 2 | 2009 | 341 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2009 | 11 | 0.080 |
Why?
|
| Mice | 3 | 2004 | 1352 | 0.080 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 13 | 0.070 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2005 | 15 | 0.070 |
Why?
|
| Electric Capacitance | 1 | 2007 | 6 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2007 | 20 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2007 | 95 | 0.070 |
Why?
|
| Permeability | 1 | 2007 | 96 | 0.070 |
Why?
|
| Receptors, CXCR4 | 2 | 2003 | 17 | 0.060 |
Why?
|
| Gene Products, gag | 1 | 2005 | 3 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 22 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 9 | 0.060 |
Why?
|
| HIV Infections | 1 | 2009 | 434 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 147 | 0.060 |
Why?
|
| Virus Replication | 2 | 2020 | 43 | 0.060 |
Why?
|
| Avian Leukosis Virus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 328 | 0.050 |
Why?
|
| Receptors, HIV | 1 | 2003 | 1 | 0.050 |
Why?
|
| Disulfides | 1 | 2003 | 10 | 0.050 |
Why?
|
| Erythrocyte Membrane | 1 | 2001 | 2 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2001 | 26 | 0.040 |
Why?
|
| Biophysics | 1 | 2001 | 32 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 2000 | 2 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2000 | 14 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 7 | 0.040 |
Why?
|
| DNA Replication | 1 | 2020 | 10 | 0.040 |
Why?
|
| Moloney murine leukemia virus | 1 | 2000 | 1 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2000 | 35 | 0.040 |
Why?
|
| Hydrostatic Pressure | 1 | 1999 | 1 | 0.040 |
Why?
|
| Surface Tension | 1 | 1999 | 3 | 0.040 |
Why?
|
| Cell Size | 1 | 1999 | 7 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 9 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2019 | 4 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 11 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 10 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 31 | 0.040 |
Why?
|
| Gene Expression | 1 | 1999 | 200 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 140 | 0.040 |
Why?
|
| Pulmonary Adenomatosis, Ovine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Jaagsiekte sheep retrovirus | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 10 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2013 | 9 | 0.030 |
Why?
|
| Sheep | 1 | 2013 | 18 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2004 | 5 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 11 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2004 | 22 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 28 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 13 | 0.010 |
Why?
|
| Chickens | 1 | 2004 | 34 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 56 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 72 | 0.010 |
Why?
|
| Reducing Agents | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2003 | 3 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 64 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 2000 | 4 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2000 | 5 | 0.010 |
Why?
|
| Leucine | 1 | 2000 | 11 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 2000 | 8 | 0.010 |
Why?
|
| Motion | 1 | 2000 | 20 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2000 | 44 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 178 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2000 | 99 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 512 | 0.010 |
Why?
|